CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) and Memorial Sloan Kettering Cancer Center (MSK) today announced the publication of new, seminal data validating FoundationOne® Heme – the fully informative comprehensive genomic profiling assay for hematologic malignancies developed as ...
Read More »
Job ID – 2015-1256 # of Openings – 1 Job Locations – US-MA-Cambridge Posted Date – 8/10/2015 Category – Research & Development Overview: Foundation Medicine is seeking a talented, highly motivated and results-oriented Scientist to join the Molecular Biology and ...
Read More »
Scientist, RNA-Seq Foundation Medicine is seeking a talented, highly motivated and results-oriented Scientist to join the Molecular Biology and Sequencing group to lead development of targeted and whole transcriptome RNA-seq assays to address unmet clinical diagnostic opportunities in oncology. The ...
Read More »
from Genetic Engineering News The National Cancer Institute (NCI) led study will investigate the unique molecular indicators of tumors associated with cancer patients with excellent prognosis to drug therapies. The study will include participation from Baylor College of Medicine, Nationwide ...
Read More »
RNA-Seq Blog Transcriptome Research & Industry News
